PanGenomic Health, Inc. Class A (TSE:NARA) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
PanGenomic Health, Inc. has updated stakeholders on the status of their management cease trade order (MCTO), which was issued due to a delay in filing their annual financial documents for the year ended December 31, 2023. The company has settled its outstanding invoices with auditors and anticipates filing the necessary documents by June 28, 2024. Trading restrictions are currently in place for the CEO and CFO, but not for shareholders, and the company will continue to provide bi-weekly status reports until the MCTO is lifted.
For further insights into TSE:NARA stock, check out TipRanks’ Stock Analysis page.